CHE vs CL · P/E 24, rev $2.43B vs P/E 34, rev $20.38B
Chemed Corp (CHE) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the CHE and CL stock pages for the full models.
Not investment advice.